Conditions · Pancreatic cancer
Pancreatic cancer — device options
5 open options
- TRIALPHASE2RECRUITING
EUS-RFA PANCARDINAL-1 Trial
Endoscopic Ultrasound (EUS)-Guided Radiofrequency Ablation (RFA) · Neoadjuvant Chemotherapy (NAC) — 1 site
- TRIALPHASE1 / PHASE2RECRUITING
Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source
Directional Brachytherapy Source Implant — 6 sites
- TRIALPHASE1 / PHASE2RECRUITING
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
LUM015 · LUM 2.6 Imaging Device — 1 site
- TRIALNARECRUITING
DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer
Point-of-care Portable Perfusion Phantom (P4) — 2 sites
- TRIALNARECRUITING
Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens
ARTIDIS ART-1 Device — 1 site
Live from ClinicalTrials.gov, refreshed at most hourly · registry query ↗
Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors.